Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FEMASYS INCFEMY · Entity 7510 | Director | June 08, 2022 | June 10, 2022 |
| MEDLEY MANAGEMENT INC.MDLY · Entity 139384 | Director | August 20, 2020 | August 21, 2020 |
| Sierra Total Return FundNONE · Entity 175498 | Director | November 09, 2016 | November 10, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FEMASYS INC
Report date June 08, 2022 · Filed June 10, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.50 · Expires 2032-06-08 | Direct | 8,500 |
Reported balance
After 2022-06-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-08 · Grant · Acquired 8,500 · Balance 8,500 F1: The shares underlying the stock option vest one year from the date of grant, assuming continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying the stock option vest one year from the date of grant, assuming continued service.
MEDLEY MANAGEMENT INC.
Report date August 20, 2020 · Filed August 21, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 94,375 |
Reported balance
After 2020-08-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-08-20 · Grant · Acquired 94,375 · Balance 94,375 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of issuer Class A common stock. F2: On the transaction date, the Reporting Person delivered his election to receive 100% of his director fees for the May 2020 to May 2021 period (the "2020-21 Term") in the form of RSUs. These director fees were approved by the issuer's board of directors on August 11, 2020 (the "Grant Date") in connection with the Reporting Person's appointment to the board on such date, with RSUs being issued to the Reporting Person covering the number of shares of Class A common stock as determined by dividing the dollar amount of director fees elected by the Reporting Person to be received in RSUs (prorated to reflect the portion of the 2020-21 Term commencing with the Reporting Person's date of appointment) by the closing price of a share of Class A common stock on the Grant Date. F3: The restricted stock units vest on May 30, 2021, provided, however, that in the event that a change in control occurs prior to such time as the restricted stock units have fully vested, the Reporting Person shall fully vest in such portion of the restricted stock units as is determined by multiplying the number of restricted stock units by a fraction, the numerator of which is the number of days elapsed between the Grant Date and the date of the change in control and the denominator of which is 293. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of issuer Class A common stock.
F2: On the transaction date, the Reporting Person delivered his election to receive 100% of his director fees for the May 2020 to May 2021 period (the "2020-21 Term") in the form of RSUs. These director fees were approved by the issuer's board of directors on August 11, 2020 (the "Grant Date") in connection with the Reporting Person's appointment to the board on such date, with RSUs being issued to the Reporting Person covering the number of shares of Class A common stock as determined by dividing the dollar amount of director fees elected by the Reporting Person to be received in RSUs (prorated to reflect the portion of the 2020-21 Term commencing with the Reporting Person's date of appointment) by the closing price of a share of Class A common stock on the Grant Date.
F3: The restricted stock units vest on May 30, 2021, provided, however, that in the event that a change in control occurs prior to such time as the restricted stock units have fully vested, the Reporting Person shall fully vest in such portion of the restricted stock units as is determined by multiplying the number of restricted stock units by a fraction, the numerator of which is the number of days elapsed between the Grant Date and the date of the change in control and the denominator of which is 293.
Sierra Total Return Fund
Report date November 09, 2016 · Filed November 10, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class T Shares of Beneficial InterestSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2016-11-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2022 Filed Jun 10, 2022 22:19 UTC | FEMASYS INC FEMY · Entity 7510 | GrantStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001140361-22-022654 · form4.xml · derivative · entry 1 Dyett John · CIK 0001610631 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option vest one year from the date of grant, assuming continued service. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 22:12 UTC | FEMASYS INC FEMY · Entity 7510 | OtherCommon Stock | 175,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-042258 · form4.xml · nonDerivative · entry 2 Dyett John · CIK 0001610631 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By the Dyett Family Trust Disclosed balance after: 290,344 F2 · kind: Pro rata distribution from Salem Femasys Investors LLC, of which the reporting person is a member and manager, to The Dyett Family Trust, of which the reporting person is the Trustee. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 22:12 UTC | FEMASYS INC FEMY · Entity 7510 | OtherCommon Stock | 3,219,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-042258 · form4.xml · nonDerivative · entry 1 Dyett John · CIK 0001610631 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Salem Femasys Investors LLC Disclosed balance after: 0 F1 · kind: As previously disclosed in the Issuer's Registration Statement on Form S-1, the shares of Common Stock held by Salem Femasys Investors LLC, of which the reporting person is a member and manager, were distributed to its members pro rata for no consideration upon the expiration of the lock-up agreement entered into in connection with the Company's initial public offering. Read SEC document |
| June 23, 2021 Filed Jun 24, 2021 20:49 UTC | FEMASYS INC FEMY · Entity 7510 | PurchaseCommon Stock | 1,000 | $9.95 | $9,950.00 |
DisclosureSEC source: 0001140361-21-022188 · form4.xml · nonDerivative · entry 7 Dyett John · CIK 0001610631 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By the Dyett Family Trust Disclosed balance after: 114,709 Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:49 UTC | FEMASYS INC FEMY · Entity 7510 | ConversionSeries C Convertible Preferred Stock · Derivative | 63,709 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-022188 · form4.xml · derivative · entry 10 Dyett John · CIK 0001610631 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By the Dyett Family Trust Disclosed balance after: 0 Underlying: Common Stock · 63,709 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: 63,709 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F4 · price: 63,709 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F4 · derivative.exercise_date: 63,709 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F4 · derivative.expiration_date: 63,709 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:49 UTC | FEMASYS INC FEMY · Entity 7510 | ConversionSeries C Convertible Preferred Stock · Derivative | 2,271,453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-022188 · form4.xml · derivative · entry 9 Dyett John · CIK 0001610631 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Salem Femasys Investors LLC Disclosed balance after: 0 Underlying: Common Stock · 2,271,453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: 2,271,453 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F3 · price: 2,271,453 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F3 · derivative.exercise_date: 2,271,453 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F3 · derivative.expiration_date: 2,271,453 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F2 · ownership.nature: Salem Femasys Investors LLC is a limited liability company consisting of 95 members, as of December 31, 2020. Mr. Dyett, acting as manager for Salem Femasys Investors LLC, has sole voting power over the shares held by Salem Femasys Investors LLC, subject to the vote of members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, and shares dispositive power over such shares, which powers may be exercised by members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, with each of the other members. Mr. Dyett disclaims beneficial ownership over the shares held by Salem Femasys Investors LLC, except to the extent of his pecuniary interest therein. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:49 UTC | FEMASYS INC FEMY · Entity 7510 | ConversionSeries B Convertible Preferred Stock · Derivative | 948,342 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-022188 · form4.xml · derivative · entry 8 Dyett John · CIK 0001610631 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Salem Femasys Investors LLC Disclosed balance after: 0 Underlying: Common Stock · 948,342 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 948,342 shares of Series B Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date. F1 · price: 948,342 shares of Series B Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date. F1 · derivative.exercise_date: 948,342 shares of Series B Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date. F1 · derivative.expiration_date: 948,342 shares of Series B Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date. F2 · ownership.nature: Salem Femasys Investors LLC is a limited liability company consisting of 95 members, as of December 31, 2020. Mr. Dyett, acting as manager for Salem Femasys Investors LLC, has sole voting power over the shares held by Salem Femasys Investors LLC, subject to the vote of members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, and shares dispositive power over such shares, which powers may be exercised by members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, with each of the other members. Mr. Dyett disclaims beneficial ownership over the shares held by Salem Femasys Investors LLC, except to the extent of his pecuniary interest therein. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:49 UTC | FEMASYS INC FEMY · Entity 7510 | ConversionCommon Stock | 63,709 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-022188 · form4.xml · nonDerivative · entry 6 Dyett John · CIK 0001610631 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By the Dyett Family Trust Disclosed balance after: 113,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: 63,709 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:49 UTC | FEMASYS INC FEMY · Entity 7510 | PurchaseCommon Stock | 40,000 | $13.00 | $520,000.00 |
DisclosureSEC source: 0001140361-21-022188 · form4.xml · nonDerivative · entry 5 Dyett John · CIK 0001610631 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By the Dyett Family Trust Disclosed balance after: 50,000 Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:49 UTC | FEMASYS INC FEMY · Entity 7510 | ConversionCommon Stock | 2,271,453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-022188 · form4.xml · nonDerivative · entry 3 Dyett John · CIK 0001610631 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Salem Femasys Investors LLC Disclosed balance after: 3,219,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: 2,271,453 shares of Series C Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F2 · ownership.nature: Salem Femasys Investors LLC is a limited liability company consisting of 95 members, as of December 31, 2020. Mr. Dyett, acting as manager for Salem Femasys Investors LLC, has sole voting power over the shares held by Salem Femasys Investors LLC, subject to the vote of members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, and shares dispositive power over such shares, which powers may be exercised by members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, with each of the other members. Mr. Dyett disclaims beneficial ownership over the shares held by Salem Femasys Investors LLC, except to the extent of his pecuniary interest therein. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:49 UTC | FEMASYS INC FEMY · Entity 7510 | ConversionCommon Stock | 948,342 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-022188 · form4.xml · nonDerivative · entry 2 Dyett John · CIK 0001610631 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Salem Femasys Investors LLC Disclosed balance after: 948,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 948,342 shares of Series B Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date. F2 · ownership.nature: Salem Femasys Investors LLC is a limited liability company consisting of 95 members, as of December 31, 2020. Mr. Dyett, acting as manager for Salem Femasys Investors LLC, has sole voting power over the shares held by Salem Femasys Investors LLC, subject to the vote of members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, and shares dispositive power over such shares, which powers may be exercised by members holding more than 50% of the outstanding interests in Salem Femasys Investors LLC, with each of the other members. Mr. Dyett disclaims beneficial ownership over the shares held by Salem Femasys Investors LLC, except to the extent of his pecuniary interest therein. Read SEC document |
| June 18, 2021 Filed Jun 24, 2021 20:49 UTC | FEMASYS INC FEMY · Entity 7510 | PurchaseCommon Stock | 10,000 | $12.88 | $128,800.00 |
DisclosureSEC source: 0001140361-21-022188 · form4.xml · nonDerivative · entry 4 Dyett John · CIK 0001610631 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By the Dyett Family Trust Disclosed balance after: 10,000 Read SEC document |
| June 18, 2021 Filed Jun 24, 2021 20:49 UTC | FEMASYS INC FEMY · Entity 7510 | PurchaseCommon Stock | 2,500 | $13.18 | $32,950.00 |
DisclosureSEC source: 0001140361-21-022188 · form4.xml · nonDerivative · entry 1 Dyett John · CIK 0001610631 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 2,500 Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 16:57 UTC | MEDLEY MANAGEMENT INC. MDLY · Entity 139384 | GrantRestricted Stock Units · Derivative | 94,375 | $0.00 | $0.00 |
DisclosureSEC source: 0000905718-20-000886 · ownership.xml · derivative · entry 1 Dyett John · CIK 0001610631 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,375 Underlying: Class A Common Stock · 94,375 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of issuer Class A common stock. F2 · date: On the transaction date, the Reporting Person delivered his election to receive 100% of his director fees for the May 2020 to May 2021 period (the "2020-21 Term") in the form of RSUs. These director fees were approved by the issuer's board of directors on August 11, 2020 (the "Grant Date") in connection with the Reporting Person's appointment to the board on such date, with RSUs being issued to the Reporting Person covering the number of shares of Class A common stock as determined by dividing the dollar amount of director fees elected by the Reporting Person to be received in RSUs (prorated to reflect the portion of the 2020-21 Term commencing with the Reporting Person's date of appointment) by the closing price of a share of Class A common stock on the Grant Date. F3 · derivative.exercise_date: The restricted stock units vest on May 30, 2021, provided, however, that in the event that a change in control occurs prior to such time as the restricted stock units have fully vested, the Reporting Person shall fully vest in such portion of the restricted stock units as is determined by multiplying the number of restricted stock units by a fraction, the numerator of which is the number of days elapsed between the Grant Date and the date of the change in control and the denominator of which is 293. F3 · derivative.expiration_date: The restricted stock units vest on May 30, 2021, provided, however, that in the event that a change in control occurs prior to such time as the restricted stock units have fully vested, the Reporting Person shall fully vest in such portion of the restricted stock units as is determined by multiplying the number of restricted stock units by a fraction, the numerator of which is the number of days elapsed between the Grant Date and the date of the change in control and the denominator of which is 293. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.